BUSINESS: International News International Seven-Year MiSight 1 Day Contact Lens Study Indicates No Myopia Control Rebound in Children By Staff Thursday, January 6, 2022 12:02 AM CooperVision announces new seven-year findings from its pivotal MiSight 1 day contact lens clinical trial. Twelve months following treatment cessation, mean axial elongation data indicate no evidence of rebound effect, meaning the myopia control gains are retained. Read More